We report in this article the clinical characteristics and treatment of two patients with a subfoveal choroidal neovascular membrane (CNVM) due to Behçet’s disease.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The development of a choroidal neovascular membrane due to Behçet’s disease is very rare.
📊
Key Findings & Data:The development of a choroidal neovascular membrane due to Behçet’s disease is very rare.
💡
Conclusion & Impact:We report in this article the clinical characteristics and treatment of two patients with a subfoveal choroidal neovascular membrane (CNVM) due to Behçet’s disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The development of a choroidal neovascular membrane due to Behçet’s disease is very rare. We report in this article the clinical characteristics and treatment of two patients with a subfoveal choroidal neovascular membrane (CNVM) due to Behçet’s disease.
Özet
Behçet Hastalığı (BH) nedeni ile koroidal neovasküler membran gelişmesi oldukça nadirdir. Bu makalede BH’ na bağlı subfoveal koroidal neovasküler membran (KNVM) gelişen iki olgunun klinik özellikleri ve tedavileri sunulmuştur.
🔖
Cite This Article
YÜKSEKKAYA, P., ÖZDAL, M. P. Ç., TEKE, M. Y., ÖZTÜRK, F. (2010). The development of a choroidal neovascular membrane due to Behçet’s disease. Retina-Vitreus, Cilt: 18 - Sayı: 2, 170–173. https://ajindex.com/articles/308093
References (14)
O’Toole L, Tufail A, Pavesio C.: Management of choroidal neovascularization in uveitis. Int Ophthalmol Clin. 2005;45:157-177
Atmaca LS, Batioğlu F, Idil A.: Retinal and disc neovascularization in Behçet’s disease and efficacy of laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1996;234:94-99
Inagaki M, Harada T, Kiribuchi T, et al.: Subfoveal choroidal neovascularization in uveitis. Ophthalmologica. 1996;210:229-233
Cummings HL, Rehmar AJ, Wood WJ, et al.: Long-term results of laser treatment in the ocular histoplasmosis syndrome. Arch Ophthalmol. 1995;113:465-468
Macular Photocoagulation Study Group: Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol. 1991;109:1109-1114
Rogers AH, Duker JS, Nichols N, et al.: Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology. 2003;110:1315-1320
Wachtlin J, Heimann H, Behme T, et al.: Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol. 2003;24:899-906
Rosenfeld PJ, Saperstein DA, Bressler NM, et al.: Verteporfin in Ocular Histoplasmosis Study Group. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Ophthalmology. 2004;111:1725-1733
Adán A, Mateo C, Navarro R, et al.: Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization. Retina. 2007;27:1180-1186
Korobelnik JF, Hannouche D, Marin F, et al.: Surgical treatment of retrofoveal choroid neovascularization in multifocal choroiditis. J Fr Ophtalmol. 1998;21:146-151
Berger AS, Conway M, Del Priore LV, et al.: Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol. 1997;115: 991-996
Michelson JB, Michelson PE, Chisari FV.: Subretinal neovascular membrane and disciform scar in Behçet’s disease. Am J Ophthalmol. 1980;90:182-185
Grossniklaus HE, Green WR.: Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol. 1998; 116:745-749
Kwak N, Okamoto N, Wood JM, et al.: VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41:3158-3164. 15.